Chemical Structure
Radicava Ors Kit
Product Images NDC 70510-2321
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Radicava Ors (NDC 70510-2321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Shionogi Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 01
Ifu Figure A
Ifu Figure B
Ifu Figure C
Ifu Figure D
Ifu Figure E
Ifu Figure F
Ifu Figure G
Ifu Figure H
Ifu Figure I
Ifu Figure J
Ifu Figure K
Ifu Figure L
Ifu Figure N
Ifu Figure O
Ifu Figure P
Ifu Figure Q
Ifui Figure M
Radicava Carton Sawaii
Radicava Carton Terumo
Radicava Ors Label Maintenance
Radicava ORS (edaravone) Oral Suspension is a medication manufactured for Mitsubishi Tanabe Pharma America, Inc. It is used for oral administration and comes in a 50 mL bottle. The suspension contains 105 mg/5 ml of edaravone and should be shaken vigorously before use. The unused portion should be discarded 15 days after first opening. It should be stored between 2-8°C (36-46°F) and protected from light. Patients should store it upright at room temperature between 20°C-25°C (88°F-77°F) and should also protect it from light. The suspension should be mixed well before each use, and dosage should be according to Prescription Information.*
Radicava Ors Label Starter
This is a description of a medication with the name Radicava ORS. This medication comes in a 35mL bottle and is used for oral administration. The medication should be shaken vigorously before each use. The unused portion should be discarded 15 days after the first opening. This medication contains 105 mg of edaravone per 5 mL, and is opaque and homogeneous. It is manufactured by Mitsubishi Tanabe Pharma America. This medication should be stored in a pharmacy between 2°C to 8°C and must not freeze while upright. Before each use, the bottle should be shaken for at least 30 seconds to confirm that the white liquid is completely mixed. The recommended dosage of this medication is indicated in the prescribing information.*
Radicava Ors Maintenance Carton
Radicava Ors Starter Carton Outer
This appears to be a jumbled mix of text and characters without any coherent meaning or context, hence it is not possible to generate a useful description.*
Radicava Ors Starter Inner Carton
Radicava Soft Bag Sawai
This appears to be a label for the medication Radicava (edaravone) injection, with a concentration of 30mg/100mL. The label provides warnings and precautions for usage and storage of the medication.*
Radicava Soft Bag Terumo
Radicava (edaravone) Injection is an intravenous infusion medication containing 30 mg edaravone per 100 mL bag. The inactive ingredients include L-cysteine hydrochloride hydrate, sodium bisulfite, sodium chloride for isotonicity, and phosphoric acid and sodium hydroxide to adjust pH. The medication should only be administered via IV infusion for 30 minutes. The package should be used within 24 hours of opening, and unused IV solution should be discarded. Radicava should not be mixed with other drugs, and the bag should be discarded if leaks are found. The medication is manufactured by Terumo Corporation in Japan and marketed by Mitsubishi Tanabe Pharma America, Inc. in Jersey City, NJ. Storage is recommended at up to 25°C (77°F).*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
